Headquartered in South Jordan, UT Fiscal year ends December NASDAQ: MMSI merit.com
Merit Medical Systems, Inc. (NASDAQ: MMSI) is a global manufacturer and marketer of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures across cardiology, radiology, oncology, critical care, and endoscopy. Founded in 1987, the company develops, manufactures, and distributes its products through a domestic and international sales force and clinical support team of more than 800 individuals, with approximately 7,500 employees worldwide. Merit organizes its product portfolio into two categories: Foundational products, which include core access and delivery devices, and Therapeutic products, which encompass interventional treatment devices. The company has been active in strategic portfolio management through acquisitions — including View Point Medical (OneMark oncology platform), C2 CryoBalloon, Biolife, Cook Medical assets, and EndoGastric Solutions — and divestitures such as the DualCap product line, as part of its Continued Growth Initiatives Program aimed at enhancing organic growth and profitability. Updated
Pre-Market Stock Futures: The futures are trading flat after a big follow-through rally on Wednesday, which fed off the big gains generated on Tuesday. The big news after the closing bell was…
Pre-Market Stock Futures: Futures are trading higher as we prepare to wrap up one of the worst trading weeks in some time. The song remains the same as the rotation out of…
Merit Medical Systems, Inc. (NASDAQ: MMSI) is a global manufacturer and marketer of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures across cardiology, radiology, oncology, critical care, and endoscopy.
24/7 Wall St.'s 12-month price target for MMSI is $119.46, rated Buy. The Wall Street consensus target is $101.64. MMSI price prediction →
